These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 27066484)

  • 21. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
    Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment.
    Dolatkhah M; Omidi Y
    Bioimpacts; 2019; 9(4):195-197. PubMed ID: 31799155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.
    Daniel SK; Sullivan KM; Labadie KP; Pillarisetty VG
    Clin Transl Med; 2019 Apr; 8(1):10. PubMed ID: 30931508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A preliminary study on the relationship between GLUT-1，MCT-4 and CAⅨ in laryngeal squamous cell carcinoma].
    Wang YB; Xu O; Zhang RJ; Shan CG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299
    [No Abstract]   [Full Text] [Related]  

  • 27. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production.
    Chafe SC; Lou Y; Sceneay J; Vallejo M; Hamilton MJ; McDonald PC; Bennewith KL; Möller A; Dedhar S
    Cancer Res; 2015 Mar; 75(6):996-1008. PubMed ID: 25623234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
    Parks SK; Cormerais Y; Durivault J; Pouyssegur J
    Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
    Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
    Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII.
    Giuntini G; Monaci S; Cau Y; Mori M; Naldini A; Carraro F
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
    Thomas JA; Gireesh Moly AG; Xavier H; Suboj P; Ladha A; Gupta G; Singh SK; Palit P; Babykutty S
    Front Oncol; 2023; 13():1063051. PubMed ID: 37056346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
    Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
    Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
    Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
    Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
    Faes S; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Datta D; Demartines N; Dormond O
    Oncotarget; 2016 Jun; 7(24):36666-36680. PubMed ID: 27153561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach.
    Jung HS; Han J; Shi H; Koo S; Singh H; Kim HJ; Sessler JL; Lee JY; Kim JH; Kim JS
    J Am Chem Soc; 2017 Jun; 139(22):7595-7602. PubMed ID: 28459562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment.
    Schito L
    Am J Physiol Regul Integr Comp Physiol; 2018 Dec; 315(6):R1072-R1084. PubMed ID: 30183339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-Sensitive Multiligand Gold Nanoplatform Targeting Carbonic Anhydrase IX Enhances the Delivery of Doxorubicin to Hypoxic Tumor Spheroids and Overcomes the Hypoxia-Induced Chemoresistance.
    Shabana AM; Mondal UK; Alam MR; Spoon T; Ross CA; Madesh M; Supuran CT; Ilies MA
    ACS Appl Mater Interfaces; 2018 May; 10(21):17792-17808. PubMed ID: 29733576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.